To evaluate the importance of CEBPA-mediated miR-29b induction in vivo, we analysed miR-29b expression in diagnostic samples of 66 AML patients, three samples of enriched CD34+ myeloid stem cells, and in samples of mature granulocytes and monocytes from 6 healthy volunteers (Figure 2). Here, CD34 is linked to acute myeloid leukemia.